276 related articles for article (PubMed ID: 29423787)
41. Safety of statin therapy in HIV/hepatitis C virus-coinfected patients.
Milazzo L; Menzaghi B; Corvasce S; Bonfanti P; Rusconi S; Ridolfo AL; Antinori S
J Acquir Immune Defic Syndr; 2007 Oct; 46(2):258-60. PubMed ID: 17895771
[No Abstract] [Full Text] [Related]
42. Statins and natural regulatory T cells in HIV infection.
Mascitelli L; Pezzetta F; Goldstein MR
HIV Med; 2008 Feb; 9(2):131. PubMed ID: 18257776
[No Abstract] [Full Text] [Related]
43. Periodic dosing regimens of atorvastatin and rosuvastatin for dyslipidemia: A systematic review and meta-analysis of randomized controlled trials.
Sridharan K; Sivaramakrishnan G
Eur J Intern Med; 2017 Apr; 39():e21-e23. PubMed ID: 28063659
[No Abstract] [Full Text] [Related]
44. Effect of chocolate and mate tea on the lipid profile of individuals with HIV/AIDS on antiretroviral therapy: A clinical trial.
Souza SJ; Petrilli AA; Teixeira AM; Pontilho PM; Carioca AA; Luzia LA; Souza JM; Damasceno NR; Segurado AA; Rondó PH
Nutrition; 2017; 43-44():61-68. PubMed ID: 28935146
[TBL] [Abstract][Full Text] [Related]
45. Is Statin Monotherapy the Perfect Polypill?
Ridker PM
Circulation; 2016 Jul; 134(2):91-3. PubMed ID: 27400893
[No Abstract] [Full Text] [Related]
46. Pharmacological management of cardiovascular conditions and diabetes in older adults with HIV infection.
Gedela K; Vibhuti M; Pozniak A; Ward B; Boffito M
HIV Med; 2014 May; 15(5):257-68. PubMed ID: 24351025
[TBL] [Abstract][Full Text] [Related]
47. A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients.
Banach M; Dinca M; Ursoniu S; Serban MC; Howard G; Mikhailidis DP; Nicholls S; Lip GYH; Glasser S; Martin SS; Muntner P; Rysz J; Toth PP; Sahebkar A;
Pharmacol Res; 2016 Sep; 111():343-356. PubMed ID: 27350264
[TBL] [Abstract][Full Text] [Related]
48. [Rhabdomyolysis and severe hepatotoxicity due to a drug-drug interaction between ritonavir and simvastatin. Could we use the most cost-effective statin in all human immunodeficiency virus-infected patients?].
Bastida C; Also MA; Pericas JM; Letang E; Tuset M; Miró JM
Enferm Infecc Microbiol Clin; 2014 Nov; 32(9):579-82. PubMed ID: 24913991
[TBL] [Abstract][Full Text] [Related]
49. Trends in Utilization of Statin Therapy and Contraindicated Statin Use in HIV--Infected Adults Treated With Antiretroviral Therapy From 2007 Through 2015.
Rosenson RS; Colantonio LD; Burkholder GA; Chen L; Muntner P
J Am Heart Assoc; 2018 Dec; 7(24):e010345. PubMed ID: 30526249
[TBL] [Abstract][Full Text] [Related]
50. Nonstatin therapies for management of dyslipidemia: a review.
Sando KR; Knight M
Clin Ther; 2015 Oct; 37(10):2153-79. PubMed ID: 26412799
[TBL] [Abstract][Full Text] [Related]
51. Effect of Rosuvastatin Therapy on Biomarkers of Inflammation and Immune Activation in People With Human Immunodeficiency Virus at Intermediate Cardiovascular Risk.
Hearps AC; Angelovich TA; Trevillyan JM; Wong ME; Calmy A; Hoy JF; Jaworowski A
J Infect Dis; 2021 Aug; 224(4):667-672. PubMed ID: 34398237
[TBL] [Abstract][Full Text] [Related]
52. Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy.
Bergersen BM
Drugs; 2006; 66(15):1971-87. PubMed ID: 17100407
[TBL] [Abstract][Full Text] [Related]
53. Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients.
Calza L; Magistrelli E; Colangeli V; Borderi M; Contadini I; Bon I; Re MC; Viale P
AIDS; 2017 Mar; 31(5):681-688. PubMed ID: 28060020
[TBL] [Abstract][Full Text] [Related]
54. Coronary heart disease in people infected with HIV.
Malvestutto CD; Aberg JA
Cleve Clin J Med; 2010 Aug; 77(8):547-56. PubMed ID: 20682517
[TBL] [Abstract][Full Text] [Related]
55. A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death.
Mesgarpour B; Gouya G; Herkner H; Reichardt B; Wolzt M
Lipids Health Dis; 2015 Oct; 14():131. PubMed ID: 26497728
[TBL] [Abstract][Full Text] [Related]
56. Long-term statin use does not act on the temporal trend of CD4 cell count in patients on virologically effective HAART.
Manfredi R; Calza L; Chiodo F
AIDS; 2006 Feb; 20(3):455-7. PubMed ID: 16439881
[TBL] [Abstract][Full Text] [Related]
57. The dyslipidemia of chronic renal disease: effects of statin therapy.
Ozsoy RC; van Leuven SI; Kastelein JJ; Arisz L; Koopman MG
Curr Opin Lipidol; 2006 Dec; 17(6):659-66. PubMed ID: 17095911
[TBL] [Abstract][Full Text] [Related]
58. Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.
Rotger M; Bayard C; Taffé P; Martinez R; Cavassini M; Bernasconi E; Battegay M; Hirschel B; Furrer H; Witteck A; Weber R; Ledergerber B; Telenti A; Tarr PE;
Circ Cardiovasc Genet; 2009 Dec; 2(6):621-8. PubMed ID: 20031643
[TBL] [Abstract][Full Text] [Related]
59. Drug safety evaluation of rosuvastatin.
Toth PP; Dayspring TD
Expert Opin Drug Saf; 2011 Nov; 10(6):969-86. PubMed ID: 21999163
[TBL] [Abstract][Full Text] [Related]
60. Factors associated with statin selection among privately insured commercial and Medicare patients.
Zhao Z; Bae J; Sponseller CA; Zhu Y; Kryzhanovski VA; LeNarz LA
Curr Med Res Opin; 2013 Apr; 29(4):395-404. PubMed ID: 23406054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
